Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Pharmacology

Background:

• Polypharmacy often leads to complex medication regimens, impacting patient adherence and health outcomes.
• Fixed-dose combination (FDC) products offer simplification but lack dose personalization, limiting efficacy.
• Cardiovascular disease, tuberculosis, and corticosteroid tapering present common challenges in managing complex medication needs.

Purpose of the Study:

• To introduce a modular titratable polypill approach for personalized medication management.
• To address the limitations of FDCs by enabling flexible dose adjustments within a single polypill.
• To simplify complex regimens in cardiovascular disease, tuberculosis, and corticosteroid therapy.

Main Methods:

• Development of a polypill system with modular units containing drugs at incremental/decremental doses.
• Assembly of modular tablets into a single titratable polypill via stacking or interlocking.
• Quality control testing of variable dose (VD) modular tablets against pharmacopeia standards.

Main Results:

• VD modular tablets met pharmacopeia acceptance criteria.
• Cost-effectiveness analysis indicated the VD strategy is more cost-effective than FDCs.
• The VD approach demonstrated greater effectiveness and lower cost than standard care.

Conclusions:

• The modular titratable polypill offers a personalized and simplified approach to polypharmacy.
• This strategy enhances treatment adherence, reduces pill burden, and provides potential cost savings.
• The VD polypill represents a significant advancement in managing complex medication regimens.